L-Ornithine-L-Aspartate Inj.

L-Ornithine-L-Aspartate Inj. Specification

Indication
Manage latent and prominent hepatic encephalopathy Manage liver cirrhosis

Salt Composition
L-Ornithine L-Aspartate

Pacakaging (Quantity Per Box)
1*20

Drug Type
Injection

Physical Form
Other

Function
Cure Liver

Suitable For
Suitable For All

Quantity
1 Unit

L-Ornithine-L-Aspartate Inj. Trade Information

Minimum Order Quantity
10 Pieces

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
5000 Pieces Per Day

Delivery Time
3 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
10 ml

Main Domestic Market
All India

About L-Ornithine-L-Aspartate Inj.

L-Ornithine L-Aspartate which belongs to the group of medicines called Amino Acids. It is used to manage latent and prominent hepatic encephalopathy (decline in brain function as a result of liver failure) and liver cirrhosis (condition in which yourliveris scarred and permanently damaged).

During management with HEPTOCHEMINJECTION, your doctor might advise you to undertake blood investigations before and during management such as kidney and liver function test to manage the risk of any unusual effects.

Avoid consuming alcohol while receiving HEPTOCHEMINJECTION. It is not recommended for use in patients with severe kidney function impairment (renal failure). Consult your doctor before receiving it.

HEPTOCHEM INJECTIONshould be used with caution in patients suffering from severe liver damage. HEPTOCHEMINJECTION is not recommended for use in pregnant and breast-feeding women unless clearly advised by the doctor.

The common side effects of receiving HEPTOCHEM INJECTION are nausea, vomiting, cough, muscle cramps and diarrhoea. Inform your doctor immediately if any of the side effect worsens or persist for a long period of time.